Boosting the detection performance of severe acute respiratory syndrome coronavirus 2 test through a sensitive optical biosensor with new superior antibody

• Published in: Bioengineering & translational medicine Vol. 8; no. 5; pp. e10410 - n/a
• Main Authors: Lin, Chih‐Yen, Wang, Wen‐Hung, Li, Meng‐Chi, Lin, Yu‐Ting, Yang, Zih‐Syuan, Urbina, Aspiro Nayim, Assavalapsakul, Wanchai, Thitithanyanont, Arunee, Chen, Kai‐Ren, Kuo, Chien‐Cheng, Lin, Yu‐Xen, Hsiao, Hui‐Hua, Lin, Kun‐Der, Lin, Shang‐Yi, Chen, Yen‐Hsu, Yu, Ming‐Lung, Su, Li‐Chen, Wang, Sheng‐Fan
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01.09.2023; Wiley
• Subjects: Antibodies; Antigens; Assaying; Biosensors; COVID-19; Disease; Laboratories; Monoclonal antibodies; monoclonal antibody; Polymerase chain reaction; Proteins; PS‐SPR; Respiratory diseases; SARS‐CoV‐2; Sensitivity analysis; Severe acute respiratory syndrome coronavirus 2; spike; spike rapid antigen test; Surface plasmon resonance; target‐captured ELISA; Viral diseases; Viruses; United States > US; target‐captured ELISA; PS‐SPR; monoclonal antibody; SARS‐CoV‐2; spike rapid antigen test; spike

The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus emerged in late 2019 leading to the COVID‐19 disease pandemic that triggered socioeconomic turmoil worldwide. A precise, prompt, and affordable diagnostic assay is essential for the detection of SARS‐CoV‐2 as well as its variants...